Cca Clinical Research

Trials Without The Tribulations CCA is a clinical research organisation (CRO) based in Surrey, UK, which specialises in Phase I, proof of concept and early-phase trials on behalf of biotechs and independent pharmaceutical companies. We manage phase I - gold-standard trials for therapeutic drugs designed to treat rare diseases, neuro-muscular conditions, such as ALS/LouGehrig’s Disease and Huntingdon’s Disease, and those affecting the endocrine system and new-born babies. Our long-standing relationships with the chief investigators, opinion-leaders and experts in these fields in the UK mean that they often recommend us to sponsors as their CRO of choice, as they trust our proven ability to manage sensitive trials with respect, efficiency and a pragmatic approach. CCA is co-owner of PSNResearch, an independent clinical research organisation headquartered in the USA and with regional offices across Europe. The group offers access to native-speaking clinical trials experts. Headquarters: 48 Station Road, Stoke D'Abernon, Cobham, Surrey KT11 3BN United Kingdom Campbell Charles Associates Ltd; Trading as CCA Clinical Research and CCA; Registered in England Number 3786328; Registered Office: 1 Paper Mews, 330 High Street, Dorking, Surrey RH4 2TU